TY - JOUR
T1 - Immediate and one-year outcome of percutaneous intervention of saphenous vein graft disease with Paclitaxel-eluting stents
AU - Tsuchida, Keiichi
AU - Ong, Andrew T.L.
AU - Aoki, Jiro
AU - Van Mieghem, Carlos A.G.
AU - Rodriguez-Granillo, Gastón A.
AU - Valgimigli, Marco
AU - Sianos, Georgios
AU - Regar, Evelyn
AU - McFadden, Eugène P.
AU - Van Der Giessen, Willem J.
AU - De Feyter, Pim J.
AU - De Jaegere, Peter P.T.
AU - Van Domburg, Ron T.
AU - Serruys, Patrick W.
PY - 2005/8/1
Y1 - 2005/8/1
N2 - The aim of this study was to evaluate the outcome after paclitaxel-eluting stent implantation in 40 patients with 52 saphenous vein graft lesions. By Kaplan-Meier estimates, the probability of major adverse cardiac event-free survival for 1 year was 92.5%. A paclitaxel-eluting stent for saphenous vein graft disease appears to be feasible and safe, with a low rate of reintervention at 1 year, but late follow-up is needed to confirm these observations.
AB - The aim of this study was to evaluate the outcome after paclitaxel-eluting stent implantation in 40 patients with 52 saphenous vein graft lesions. By Kaplan-Meier estimates, the probability of major adverse cardiac event-free survival for 1 year was 92.5%. A paclitaxel-eluting stent for saphenous vein graft disease appears to be feasible and safe, with a low rate of reintervention at 1 year, but late follow-up is needed to confirm these observations.
UR - http://www.scopus.com/inward/record.url?scp=23044442806&partnerID=8YFLogxK
U2 - 10.1016/j.amjcard.2005.03.084
DO - 10.1016/j.amjcard.2005.03.084
M3 - Article
C2 - 16054466
AN - SCOPUS:23044442806
SN - 0002-9149
VL - 96
SP - 395
EP - 398
JO - American Journal of Cardiology
JF - American Journal of Cardiology
IS - 3
ER -
